Frontiers | Insulin Resistance in HIV-Patients: Causes and Consequences
SciELO - Brasil - Influence of AIDS antiretroviral therapy on the growth pattern Influence of AIDS antiretroviral therapy on the growth pattern
HIV infection does not alter interferon α/β receptor 2 expression on mucosal immune cells | PLOS ONE
HIGH-FREQUENCY failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal NON-ADHERENCE - eClinicalMedicine
Management of HIV/AIDS - Wikipedia
Pharmaceutics | Free Full-Text | Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients
:max_bytes(150000):strip_icc()/doctor-teaching-patients-how-to-use-pill-dispenser-576621694-578bc6295f9b584d20e4fc8d.jpg "Combination Antiretroviral Therapy (cART) for HIV")
Combination Antiretroviral Therapy (cART) for HIV
JCI - Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs
Role of Dysregulated Autophagy in HIV Tat, Cocaine, and cART Mediated NLRP3 Activation in Microglia | SpringerLink
Molecular Mechanisms Controlling HIV Transcription and Latency – Implications for Therapeutic Viral Reactivation | IntechOpen
Frontiers | Advances in Developing CAR T-Cell Therapy for HIV Cure
HIV-1 transcription and latency: an update | Retrovirology | Full Text
Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice | Journal of Translational Medicine | Full Text
Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection | Nature Reviews Drug Discovery
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames? | Current HIV/AIDS Reports
Frontiers | Advances in Developing CAR T-Cell Therapy for HIV Cure
Full article: Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt/β-catenin/TCF1 axis in CD4+ T cells
HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells | aidsmap
Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults - ScienceDirect
SWORD Study: Switch to DTG + RPV
Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection | Science Translational Medicine
Nanomedicine applications towards the cure of HIV - ScienceDirect
Bone loss associated with HIV infection and initiated by cART. a | The... | Download Scientific Diagram
HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women - ScienceDirect
HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies | Open Heart
